Biohaven (BHVN) Ownership - Who owns Biohaven?

7 days until earnings call

Profile

Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.18B
P/E Ratio
N/A
Total Cash
283.42M
Projected Growth
N/A
Total Debt
30.53M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.21
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

BHVN
Capitalization
3.18B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
283M
Total Cash/Share
3.21
Total Debt
30.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
301M
P/B Ratio
10.54
Cash Flow
N/A
Earnings
-6.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
911M
Current Ratio
4.03
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-534.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-99.74
Shares Held By Institutions
5.26B
Shares Outstanding - Current
88.3M
Total Liabilities
117M
Total Volume MTD
N/A
Value
-1
Gain YTD
-15.935
View a ticker or compare two or three
BHVN
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com